Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04350359 · ClinicalTrials.gov registry record · NA
Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder
A NA study of Spinal Cord Injuries, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 2
- Study locations
NCT04350359: Recruiting NA study of Spinal Cord Injuries, sponsored by The University of Texas Health Science Center, Houston.
NCT04350359 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 120 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (97% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04350359, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if electric stimulation to the leg, called transcutaneous tibial nerve stimulation (TTNS), can improve bladder outcomes in acute spinal cord injury.
Primary Outcome
we expect bladder capacity to be maintained in those with effective TTNS
Conditions Studied
Interventions
- DEVICE Variable-dose TTNS Protocol 5 x week
- DEVICE Fixed-dose TTNS Protocol
- DEVICE Variable-dose TTNS Protocol 2 x week
Study Locations (2)
District of Columbia
- MedStar National Rehabilitation Hospital - Washington D.C.
Texas
- TIRR Memorial Hermann Research Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-06-08 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What NCT04350359 shows while recruiting
NCT04350359 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (97% higher).
The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 3 interventions - of which Variable-dose TTNS Protocol 5 x week is the first listed.
NCT04350359 reports a single indexed study location in District of Columbia, Texas.
Frequently Asked Questions
What is clinical trial NCT04350359 about?
NCT04350359 is a clinical study titled "Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder". The purpose of this study is to determine if electric stimulation to the leg, called transcutaneous tibial nerve stimulation (TTNS), can improve bladder outcomes in acute spinal cord injury.
What is the current status of trial NCT04350359?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2020-06-08. Estimated completion is 2026-07-01.
What conditions does trial NCT04350359 study?
This clinical trial studies the following conditions: Spinal Cord Injuries.
What interventions are being tested in trial NCT04350359?
The interventions under investigation include: Variable-dose TTNS Protocol 5 x week (DEVICE), Fixed-dose TTNS Protocol (DEVICE), Variable-dose TTNS Protocol 2 x week (DEVICE).
Who is sponsoring clinical trial NCT04350359?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04350359 being conducted?
This trial has 2 study locations across District of Columbia, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04350359's enrollment target sits among peer trials
120 25th of 202 higher than 176 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy